Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Xxlofoten AS
AS
Active
Org 987734841
Johan E. Paulsens Gate 9, 8300
Svolvær
Amusement and recreation activities n.e.c.
·
NACE 9329
Est. 2005 · 21 years old
27 employees
Monitor
Share
Norway
/
Companies
/
Amusement and recreation activities n.e.c.
/
Xxlofoten AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
51M
38M
26M
13M
0M
2021: 18M
18M
2021
2022: 24M (+33% vs 2021)
24M
+33%
2022
2023: 28M (+17% vs 2022)
28M
+17%
2023
2024: 40M (+43% vs 2023)
40M
+43%
2024
2025: 41M (+3% vs 2024)
41M
+3%
2025
EBITDA
NOK millions
7M
6M
4M
2M
0M
2021: 6M
6M
2021
2022: 6M (0% vs 2021)
6M
0%
2022
2023: 6M (0% vs 2022)
6M
0%
2023
2024: 6M (0% vs 2023)
6M
0%
2024
2025: 5M (-17% vs 2024)
5M
-17%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
40 955
40 048
27 931
23 982
18 013
Staff expenses
−9 822
−7 636
−4 688
−4 446
−2 987
EBITDA
4 880
5 656
6 340
5 854
5 540
Depreciation & amort.
−1 029
−1 202
−943
−1 039
−824
EBIT
3 852
4 454
5 397
4 815
4 717
Net financials
167
−16
−305
−200
−348
Profit before tax
4 019
4 438
5 092
4 615
4 369
Tax
884
982
1 126
375
−0
Net profit
3 134
3 456
3 966
4 240
4 369
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
24 921
26 745
21 186
25 979
22 053
Equity
4 859
5 156
6 504
16 610
12 371
Long-term debt
5 468
6 089
7 004
7 617
7 833
Short-term debt
14 593
15 500
7 678
1 751
1 849
Total debt
20 062
21 590
14 682
9 369
9 682
Financial ratios
5-year trend
EBITDA margin
11,9 %
This company
15,8 %
Market median
This company
Market median
25% below market
2021
2025
Equity ratio
19,5 %
This company
38,2 %
Market median
This company
Market median
49% below market
2021
2025
Return on equity
64,5 %
This company
18,4 %
Market median
This company
Market median
251% above market
2021
2025
Net profit margin
7,7 %
This company
8,1 %
Market median
This company
Market median
5% below market
2021
2025
Asset turnover
1,64×
This company
1,12×
Market median
This company
Market median
46% above market
2021
2025
Debt / equity
4,13×
This company
0,62×
Market median
This company
Market median
566% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Xxlofoten AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
